Company Data
Xencor Inc.
Ticker
XNCR
Current Price
$8 3.43%
Market Cap
$569.4M
Price Target
Refer to Report
Volume
1.3M
52wk Range
$7.16 - $27.24
Overview
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.